Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cerilliant
Fish and Richardson
Healthtrust
Dow
Baxter
Merck
Covington
Express Scripts

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR KEFLEX

« Back to Dashboard

Clinical Trials for Keflex

Trial ID Title Status Sponsor Phase Summary
NCT00300092 Pediatric Fingertip Injuries:Are Antibiotics Required? Completed Children's Hospital Los Angeles Phase 2 Study objective: Fingertip injuries are common in the pediatric population. Considerable controversy exists about whether prophylactic antibiotics are necessary after repair of such injuries. Our goals were to estimate the rate of bacterial infection among pediatric patients with distal fingertip injuries overall and to compare the rate of bacterial infections among subgroups treated with and without prophylactic antibiotics. Methods: This was prospective randomized control study of pediatric patients presenting to an urban children's hospital with trauma to the distal fingertip requiring repair. Patients were randomized to two groups: those receiving prophylactic antibiotics (Cephalexin) and those who did not receive antibiotic therapy. Repairs were performed in a standardized fashion and all patients were re-evaluated in the same emergency department in 48 hours and by phone 7 days later. The primary outcome of this study was the incidence of infection.
NCT01073540 Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension Completed Corporación Bonima S.A. de C.V. Phase 1 A single dose, two treatments (two cephalexin suspension brands), two sequences, cross-over design was used with a washout of 7 days between the two study periods. Treatment groups balanced with the same number of healthy volunteers who were randomly (in two strata: male and female) assigned to the study drug administration sequences.
NCT01073540 Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension Completed Bayer Phase 1 A single dose, two treatments (two cephalexin suspension brands), two sequences, cross-over design was used with a washout of 7 days between the two study periods. Treatment groups balanced with the same number of healthy volunteers who were randomly (in two strata: male and female) assigned to the study drug administration sequences.
NCT01073553 Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules Completed Corporación Bonima S.A. de C.V. Phase 1 A single dose, two treatments (two cephalexin capsules brands), two sequences, cross-over design was used with a washout of 7 days between the two study periods. Treatment groups balanced with the same number of healthy volunteers who were randomly (in two strata: male and female) assigned to the study drug administration sequences.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Keflex

Condition Name

Condition Name for Keflex
Intervention Trials
Healthy Volunteers 4
Infections, Respiratory Tract 3
Anti-Infective Agents 3
Urinary Tract Infections 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Keflex
Intervention Trials
Respiratory Tract Infections 3
Urinary Tract Infections 2
Infection 2
Communicable Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Keflex

Trials by Country

Trials by Country for Keflex
Location Trials
Mexico 8
United States 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Keflex
Location Trials
California 2
Michigan 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Keflex

Clinical Trial Phase

Clinical Trial Phase for Keflex
Clinical Trial Phase Trials
Phase 4 1
Phase 2 2
Phase 1 13
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Keflex
Clinical Trial Phase Trials
Completed 12
Recruiting 3
Unknown status 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Keflex

Sponsor Name

Sponsor Name for Keflex
Sponsor Trials
Eli Lilly and Company 5
Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V. 5
GlaxoSmithKline 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Keflex
Sponsor Trials
Industry 15
Other 13
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Teva
Cipla
Healthtrust
Chinese Patent Office
Fish and Richardson
Federal Trade Commission
US Army
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.